EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Carbon Fiber and Titanium Surgical Implants for Proton and Photon Therapy

Nicolas Depauw, Jennifer Pursley, Santiago A Lozano-Calderon, Chirayu G Patel

Practical Radiation Oncology · 2023

DOI: 10.1016/j.prro.2023.01.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2023. Verfasst von Nicolas Depauw und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Titanium, Proton Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: MASSACHUSETTS GENERAL HOSPITAL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Impending and actual pathologic fractures secondary to metastatic bone disease, lymphoma, or multiple myeloma often require intramedullary fixation followed by radiation therapy. Because of carbon's low atomic number, there are reduced computed tomography (CT) imaging artifacts and dose perturbation when planning postoperative radiation for carbon fiber (CF) rods. Herein, we characterize the dosimetric properties of CF implants compared with titanium alloy (TA) for proton and photon. METHODS AND MATERIALS: TA and CF samples were acquired from an implant manufacturer. Material characteristics were evaluated by CT scans with and without metal artifact reduction (MAR). Relative stopping power (RSP) was determined from the range pull-back of each sample in a 20-cm range proton beam. Photon transmission measurements were made in a solid water phantom and compared with the modeled dosimetry from the RayStation planning system. RESULTS: CF caused no visible CT artifacts, and MAR was not necessary for Hounsfield unit (HU) determination (median, 364 HU) or contouring, whereas TA (median, 3071 HU) caused substantial artifacts, which were improved, but not eliminated by MAR. The proton RSP was measured as 3.204 for TA and 1.414 for CF. For 6 MV photons, the measured transmission was 89.3% for TA and 98% for CF. CF RSP calculation and transmission from CT HU showed a physical density overestimate compared with measurements, which would cause a slight, but acceptable, dose uncertainty (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TitaniumProton TherapyHumansCarbon FiberProtonsTomography, X-Ray ComputedRadiometryPhantoms, ImagingArtifactsRadiotherapy Planning, Computer-Assisted

Substanzen

TitaniumCarbon FiberProtons

Autor:innen und Institutionen

  • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: cpatel@mgh.harvard.edu.

Förderung

  • MASSACHUSETTS GENERAL HOSPITAL

Zitieren

APA

Depauw, N., Pursley, J., Lozano-Calderon, S. A., & Patel, C. G. (2023). Evaluation of Carbon Fiber and Titanium Surgical Implants for Proton and Photon Therapy. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2023.01.009

Vancouver

Depauw N, Pursley J, Lozano-Calderon SA, Patel CG. Evaluation of Carbon Fiber and Titanium Surgical Implants for Proton and Photon Therapy. Practical Radiation Oncology. 2023. doi:10.1016/j.prro.2023.01.009

BibTeX
@article{Depauw2023,
  author = {Depauw, Nicolas and Pursley, Jennifer and Lozano-Calderon, Santiago A and Patel, Chirayu G},
  title = {Evaluation of Carbon Fiber and Titanium Surgical Implants for Proton and Photon Therapy},
  journal = {Practical Radiation Oncology},
  year = {2023},
  doi = {10.1016/j.prro.2023.01.009}
}
Kostenlos starten →